Intertek Expert to Present on Advanced Approaches to Immunogenicity Assessment
15 Jan 2013
San Diego, United States – Intertek, a leading provider of quality and safety services to a wide range of industries around the world, will highlight advanced approaches to clinical immunogenicity assessment at Immunogenicity & Immunotoxicity, January 31st, San Diego, USA.
This inaugural conference, which takes place in San Diego, USA, brings together leading experts in industry, academia and the FDA. The important topics that will be covered include progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.
Nancy Emtage, Bioanalytical Immunochemistry expert in cell based Neutralization assay, Intertek Pharmaceutical Services will present on “Development and Validation of A Cell Based Assay for the Detection of Neutralizing Antibodies in Serum in Presence of High Levels of Drugs” as part of the ‘Clinical Relevance of Immunogenicity’ conference track.
“It is important to understand the immune response to a novel biologic drug” says Dr Gouty, Senior Director, Intertek Pharmaceutical Services, “Each method and each compound is evaluated in a uniquely specific way in order to optimize the approach to assay development and ensure a comprehensive, scientifically sound validation, sometimes this means that advanced approaches are required to address potential challenges.” Dr Emtage will describe advanced approaches to assess the level of neutralization antibodies in serum.
Intertek Pharmaceutical Services Immunochemistry develops and validates GLP compliant a wide range of cell-based and receptor-based assays for determining the presence of neutralizing antibodies. For more information, please visit: https://www.intertek.com/pharmaceutical/immunochemistry/
Media Contacts:
For further information, please contact:
Joel Pekay, Sales and Marketing Director
Intertek Chemicals & Pharmaceuticals
Tel: +1 312 906 7716
Email: joel.pekay@intertek.com
Dr Lorna Kettle, Sales & Marketing,
Intertek Pharmaceutical Services
Tel: +44 161 721 1476
Email: lorna.kettle@intertek.com
About Intertek
Intertek (ITRK.L) is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers’ products and processes, supporting their success in the global marketplace. With a network of more than 1,000 laboratories and offices and over 33,000 people in more than 100 countries, Intertek helps its clients to meet end users’ expectations across increasingly diverse quality, health, environmental, safety and social accountability aspects in virtually any market around the world. Visit www.intertek.com